ArticleVaccines2022

Inefficient Induction of Neutralizing Antibodies against SARS-CoV-2 Variants in Patients with Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor Therapy after Receiving a Third mRNA Vaccine Dose.

Paola López-Marte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.